NCT03412552View on ClinicalTrials.gov

Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia

CompletedOBSERVATIONAL
Enrollment

1,238

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

October 1, 2017

Study Completion Date

December 30, 2017

Conditions
Hypertensive Disorder of Pregnancy
Interventions
DRUG

MgSO4

Loading dose of magensium sulphate (4-6g I.V), given over 20 minutes in 100 ml of dextrose, Maintenance dose (4-6g) magensium sulphate in 500 cc dextrose given over 8 hours using continuous IV drip

Trial Locations (1)

12151

Kasr Alainy medical school, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03412552 - Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia | Biotech Hunter | Biotech Hunter